New Gene-Drug Reference Guide!

Who Should Get Tested?

It’s one of the most common questions we get from providers.

We’ve developed this new free guide to help you save time and minimize the risks of side effects, treatment failure and drug-drug interactions. Our guide also helps you quickly identify when a patient is an ideal candidate for PGx testing!

Preview of the Who Should Get Tested PDF

Consider Genomind testing for patients meeting any of the criteria below:

  • Failed medications or experiencing treatment resistance across behavioral health, pain management, cardiology, or gastroenterology
  • Experiencing adverse drug reactions (ADRs) or chronic conditions requiring polypharmacy
  • Prescribed or being considered for one of the medications mentioned in our guide with published PGx guidance

Tell us your email, and we’ll send you a copy!

We're dedicated to safeguarding your privacy. Genomind will use the information you submit to contact you regarding our relevant content, products, and services. You can unsubscribe from these communications anytime. For further details, check out our Privacy Policy.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Genomind’s clinical experts reviewed hundreds of pages of FDA, CPIC, and DPWG guidance to develop this streamlined reference guide with important actionable gene-drug pairings. Some risks associated with the drugs listed in the attached guide can be mitigated with PGx testing. Special consideration should be given to the medications listed at the bottom of the attached guide due to the risk of potentially life-threatening Adverse Drug Reactions.